⌘K

Enzon Pharmaceuticals, Inc. (ENZN)

$0.08 5.26% $0.00 Healthcare

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Market cap

$5.94M

CEO

Mr. Andrew Rackear J.D.

Headquarters

Cranford, NJ

IPO Date

Feb 15, 1984

Price-to-earnings (PE) Ratio

8.00

Earnings-per-share (EPS)

$0.01

Cash ratio (TTM)

106.47

Current ratio (TTM)

107.24

Earnings yield (TTM)

25.63%

Net profit margin (TTM)

5,853.85%

PE ratio (TTM)

3.90

PEG ratio (TTM)

-0.10

Price-to-book ratio (TTM)

2.15

Price-to-sales ratio (TTM)

228.35

Quick ratio (TTM)

107.24

Return on assets (TTM)

3.22%

Return on equity (TTM)

4.30%

Similar stocks (6)

PureTech Health plc

PRTC

$22.55 0.22% $0.05

Downtrend

Eliem Therapeutics, Inc.

ELYM

$5.11 -0.97% $-0.05

Downtrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.52 1.55% $0.13

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.66 -5.41% $-0.10

Neutral

Kineta, Inc.

$0.57 -30.77% $-0.26

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$0.41 -8.69% $-0.04

Downtrend

Similar stocks (6)

PureTech Health plc

PRTC

$22.55 0.22% $0.05

Downtrend

Eliem Therapeutics, Inc.

ELYM

$5.11 -0.97% $-0.05

Downtrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.52 1.55% $0.13

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.66 -5.41% $-0.10

Neutral

Kineta, Inc.

$0.57 -30.77% $-0.26

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$0.41 -8.69% $-0.04

Downtrend